NEUROPROTECTIVE EFFECT OF ENDACANNABINOID N-ARACHIDONOYLDOPAMINE IN ACUTE HYPOBARIC HYPOXIA

Elena V Mitroshina , Maria V Vedunova , Andrei A Mironov , Tatyana A Saharnova , Alexei S Pimashkin , Mikhail Y Bobrov , Leonid G Khaspeckov , Irina V Mukhin

Neurology Bulletin ›› 2012, Vol. XLIV ›› Issue (1) : 14 -19.

PDF
Neurology Bulletin ›› 2012, Vol. XLIV ›› Issue (1) : 14 -19. DOI: 10.17816/nb13724
Articles
other

NEUROPROTECTIVE EFFECT OF ENDACANNABINOID N-ARACHIDONOYLDOPAMINE IN ACUTE HYPOBARIC HYPOXIA

Author information +
History +
PDF

Abstract

The effect of the endogenous cannabinoid N-arachi-donoyldopamin (AA-DA) in acute hypobaric hypoxia in mice was studied. The lifetime of the animals at the height, survival, changes in locomotor activity with the test «open field» and the long-term memory with test «Morris water maze» were evaluated. It was revealed that injection of AA-DA significantly increased survival animals and long-term memory in remote period of acute hypoxia. Neuroprotective effect of AA-DA was shown.

Keywords

endocannabinoid system / neuroprotection / N-arahidonoildophamin / acute hypobaric hypoxia

Cite this article

Download citation ▾
Elena V Mitroshina, Maria V Vedunova, Andrei A Mironov, Tatyana A Saharnova, Alexei S Pimashkin, Mikhail Y Bobrov, Leonid G Khaspeckov, Irina V Mukhin. NEUROPROTECTIVE EFFECT OF ENDACANNABINOID N-ARACHIDONOYLDOPAMINE IN ACUTE HYPOBARIC HYPOXIA. Neurology Bulletin, 2012, XLIV(1): 14-19 DOI:10.17816/nb13724

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1. Бобров М.Ю., Генрихс Е.Е., Барсков И.В. и др. Нейропротекторный эффект модуляторов эндогенной каннабиноидной системы при экспериментальной церебральной ишемии / В кн.: Рецепторы и внутриклеточная сигнализация. - 2011, Пущино. - Т. 1. - С. 94-98.

[2]

2. Методические рекомендации по экспериментальному изучению препаратов, предлагаемых для клинического изучения в качестве антигипоксических средств. - М., 1990. - 18 с.

[3]

3. Хаспеков Л.Г., Бобров М.Ю. Эндогенная канна-биноидная система и ее защитная роль // Нейрохимия. - 2006. - Т. 23, №2. - С. 85-105.

[4]

4. Bisogno T., Melck D., Bobrov M. Yuю et al. N-acyl-dopamines : novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo // Biochem. J. - 2000. - Vol. 351. - P. 817-824.

[5]

5. Bobrov M.Y., Lizhin A.A., Andrianova E.L. et al. Antioxidant and neuroprotective properties of N-arachido-noyldopamine // Neurosci. Lett. - 2008. - Vol. 431, №1. - P. 6-11.

[6]

6. D'Hooge R., De Deyn P.P. Application for the Morris water maze in the study of learning and memory // Brain Res. Rev. - 2001. - №36. - Р. 60-90.

[7]

7. Herkenham M., Lynn A.B., Johnson M.R. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study // J. Neurosci. - 1991. - Vol. 11. - P.563-568.

[8]

8. Kano M., Ohno-Shosaku T., Hashimotodani Y. et al. Endocannabinoid-mediated control of synaptic transmission // Physiol Rev. - 2009. - Vol. 89, №1. - Р. 309-380.

[9]

9. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system // Handbook of experi-mental pharmacology. - 2005. - Vol. 168. - P. 299-325.

[10]

10. Mechoulam R., Panikashvili D and Shohami E. Cannabinoids and brain injury: therapeutic implications // TRENDS in Molecular Medicine. - 2002. - Vol.8, №2. - P. 58-61.

[11]

11. Morgan N.H., Stanford I.M., Woodhall G.L. Functional CB2 type cannabinoid receptors at CNS synapses // Neuropharmacology. - 2009. - Vol. 57, №4. - P. 356-368.

[12]

12. Morris R.G.M., Garrud P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions // Nature. - 1982. - №297. - Р. 681-683.

[13]

13. Panikashvili D., Simeonidou C., Ben-Shabat S. et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury // Nature. - 2001. - Vol. 413. - P. 527-531.

[14]

14. Pertwee R.G. Cannabinoid pharmacology: the first 66 years // British Journal of Pharmacology. - 2006. - Vol. 147. - P. S163-S171.

[15]

15. Riedel G., Davies S.N. Cannabinoid function in learning, memory and plasticity / In: Cannabinoids. Handbook of Experi-mental Pharmacology. - 2005. - Vol. 168. - P 445-477.

[16]

16. Schomacher M., Mьller H. D., Sommer C. et al. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia // Brain Research. - 2008. - Vol. 1240. - P. 213-220.

[17]

17. Szabo B. Pharmacology of cannabinoid receptors // Biotrend reviews. - 2008. - №2. - P. 1-13.

[18]

18. Szabo B., Schlicker E. Effects of Cannabinoids on Neurotransmission / In: Cannabinoids. Handbook of Experimental Pharmacology. - 2005. - Vol. 168. - P. 327-365.

RIGHTS & PERMISSIONS

Mitroshina E.V., Vedunova M.V., Mironov A.A., Saharnova T.A., Pimashkin A.S., Bobrov M.Y., Khaspeckov L.G., Mukhin I.V.

AI Summary AI Mindmap
PDF

116

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/